Delivery Order SPE2DB20D7066-SPE2DB25FC4GW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,223.51. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 9, 2025, and is being performed at the contractor's Conshohocken facility. No set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $4,698.53. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (60-count units) with a ceiling value of $19,258.50. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 8, 2025, with a ceiling value of $6,644.43 and firm fixed pricing. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,063.89 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180 count) under a firm fixed price contract. This non-set-aside award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets in a quantity of 180 units, with a ceiling value of $4,327.00. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4GWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $5,460.68. This firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement requirements. Performance is scheduled for completion by August 11, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the DLA encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Janumet—a diabetes medication combining metformin and sitagliptin—exemplifies the company's role in supplying essential pharmaceuticals to support Department of Defense healthcare operations and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/8/25 |